Manuela Monti

1.1k total citations
47 papers, 757 citations indexed

About

Manuela Monti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Manuela Monti has authored 47 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Manuela Monti's work include Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (9 papers). Manuela Monti is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (9 papers). Manuela Monti collaborates with scholars based in Italy, France and Germany. Manuela Monti's co-authors include Giovanni Paganelli, Stefano Severi, Maddalena Sansovini, Anna Sarnelli, Silvia Nicolini, Emanuela Scarpi, Annarita Ianniello, Valentina Di Iorio, Lisa Bodei and Federica Matteucci and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Manuela Monti

42 papers receiving 751 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Manuela Monti 477 448 341 232 192 47 757
Silvia Nicolini 551 1.2× 549 1.2× 438 1.3× 300 1.3× 259 1.3× 30 931
Marianne E. Pavel 470 1.0× 564 1.3× 369 1.1× 256 1.1× 98 0.5× 11 748
Valentina Di Iorio 232 0.5× 220 0.5× 168 0.5× 206 0.9× 180 0.9× 31 476
Angelina Filice 289 0.6× 323 0.7× 186 0.5× 230 1.0× 167 0.9× 53 772
Camilla Bardram Johnbeck 392 0.8× 428 1.0× 283 0.8× 371 1.6× 114 0.6× 23 857
Karin Niepsch 359 0.8× 291 0.6× 198 0.6× 329 1.4× 279 1.5× 13 588
Johanna Svensson 272 0.6× 355 0.8× 171 0.5× 509 2.2× 156 0.8× 38 792
Jan-Paul Esser 485 1.0× 606 1.4× 422 1.2× 242 1.0× 55 0.3× 6 751
Stefano Severi 1.1k 2.3× 1.1k 2.5× 837 2.5× 407 1.8× 246 1.3× 59 1.6k
Bernhard Nilica 327 0.7× 272 0.6× 181 0.5× 410 1.8× 420 2.2× 27 855

Countries citing papers authored by Manuela Monti

Since Specialization
Citations

This map shows the geographic impact of Manuela Monti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Monti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Monti more than expected).

Fields of papers citing papers by Manuela Monti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Monti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Monti. The network helps show where Manuela Monti may publish in the future.

Co-authorship network of co-authors of Manuela Monti

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Monti. A scholar is included among the top collaborators of Manuela Monti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Monti. Manuela Monti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iorio, Valentina Di, Stefano Boschi, Maddalena Sansovini, et al.. (2025). How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience. Pharmaceuticals. 18(11). 1709–1709.
2.
Grassi, Ilaria, Silvia Nicolini, Irene Marini, et al.. (2024). Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study. Neuroendocrinology. 115(5). 434–445. 1 indexed citations
3.
Sansovini, Maddalena, Manuela Monti, Giovanni Paganelli, et al.. (2023). Radioligand therapies in cancer: mapping the educational landscape in Europe. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2692–2698. 2 indexed citations
4.
Feliciani, Giacomo, Manuela Monti, Ignazio Stanganelli, et al.. (2022). A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study. Cancers. 14(1). 240–240. 5 indexed citations
5.
Giorgi, Ugo De, Maddalena Sansovini, Stefano Severi, et al.. (2021). Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial. British Journal of Cancer. 125(9). 1226–1232. 20 indexed citations
6.
Cenni, P., Elisa Neri, Manuela Monti, et al.. (2021). Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma. Frontiers in Oncology. 11. 643469–643469. 6 indexed citations
7.
Nicolini, Silvia, Lisa Bodei, Alberto Bongiovanni, et al.. (2021). Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3260–3267. 43 indexed citations
8.
Marini, Irene, Maddalena Sansovini, Alberto Bongiovanni, et al.. (2021). Theragnostic in neuroendocrine tumors. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 65(4). 342–352. 4 indexed citations
9.
Fabbri, Francesca, Patrizia Serra, Bernadette Vertogen, et al.. (2020). How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool. JCO Oncology Practice. 17(1). e68–e76. 7 indexed citations
10.
Caroli, Paola, Ugo De Giorgi, Monica Celli, et al.. (2020). 68Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy. Biomedicines. 8(12). 536–536. 11 indexed citations
11.
Paganelli, Giovanni, Maddalena Sansovini, Silvia Nicolini, et al.. (2020). 177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 152–160. 24 indexed citations
12.
Cagnazzo, Celeste, et al.. (2019). Ricerca clinica: abbastanza giocatori per vincere la partita?. Recenti Progressi in Medicina. 110(6). 285–291. 4 indexed citations
13.
Sarnelli, Anna, Maria Luisa Belli, Valentina Di Iorio, et al.. (2019). Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol. Molecules. 24(3). 621–621. 35 indexed citations
14.
Cagnazzo, Celeste, et al.. (2019). Coordinatori di ricerca clinica: una risorsa indispensabile. Recenti Progressi in Medicina. 110(2). 65–67. 8 indexed citations
15.
Rocca, Andrea, Lorenzo Cecconetto, Alessandro Passardi, et al.. (2017). Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology. 79(5). 863–871. 15 indexed citations
16.
17.
Severi, Stefano, Maddalena Sansovini, Annarita Ianniello, et al.. (2015). Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC. European Journal of Nuclear Medicine and Molecular Imaging. 42(13). 1955–1963. 51 indexed citations
18.
Paganelli, Giovanni, Maddalena Sansovini, A. Ambrosetti, et al.. (2014). 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study. European Journal of Nuclear Medicine and Molecular Imaging. 41(10). 1845–1851. 96 indexed citations
19.
Genestreti, Giovenzio, Luca Ampollini, Marco Angelo Burgio, et al.. (2013). Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETs): An Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone). Annals of Surgical Oncology. 20(9). 2958–2963. 1 indexed citations
20.
Sansovini, Maddalena, Stefano Severi, A. Ambrosetti, et al.. (2013). Treatment with the Radiolabelled Somatostatin Analog <sup>177</sup>Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 97(4). 347–354. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Nicolini Breakdown of academic impact, for papers by Marianne E. Pavel Breakdown of academic impact, for papers by Valentina Di Iorio Breakdown of academic impact, for papers by Angelina Filice Breakdown of academic impact, for papers by Camilla Bardram Johnbeck Breakdown of academic impact, for papers by Karin Niepsch Breakdown of academic impact, for papers by Johanna Svensson Breakdown of academic impact, for papers by Jan-Paul Esser Breakdown of academic impact, for papers by Stefano Severi Breakdown of academic impact, for papers by Bernhard Nilica
Rankless by CCL
2026